Ling Rong
Impact in
- Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Advanced Glycation End Products research 15
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Co-authors
- Ann Marie SchmidtThoralf WendtLoredana BucciarelliShi Fang YanWu QuDavid M. SternYan LüEvanthia Lalla
- Journals
- Journal of Clinical Investigation (2 papers)Biomedicine & Pharmacotherapy (2 papers)Respirology (2 papers)The FASEB Journal (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ling Rong
34 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 97
- Clinical Biochemistry 2.1k
- Endocrinology, Diabetes and Metabolism 950
- Nephrology 356
- Neurology 249
- Immunology 404
Countries citing papers authored by Ling Rong
This map shows the geographic impact of Ling Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Rong more than expected).
Fields of papers citing papers by Ling Rong
This network shows the impact of papers produced by Ling Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Rong. The network helps show where Ling Rong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2019 | 25 | |
| 5 | 2018 | 28 | |
| 6 | 2017 | 14 | |
| 7 | Alkaloids from root tubers of Stephania kwangsiensis H.S.Lo and their effects on proliferation and apoptosis of lung NCI-H446 cells. | 2016 | 7 |
| 8 | 2015 | 4 | |
| 9 | 2015 | 14 | |
| 10 | 2014 | 19 | |
| 11 | 2009 | 1 | |
| 12 | 2009 | 14 | |
| 13 | 2007 | 32 | |
| 14 | 2005 | 185 | |
| 15 | 2005 | 47 | |
| 16 | 2005 | 80 | |
| 17 | 2004 | 73 | |
| 18 | 2003 | 296 | |
| 19 | 2003 | 484 | |
| 20 | 2002 | 250 |
About Ling Rong
Ling Rong is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Neurology, Toxicology and Emergency Medical Services, having authored 36 papers that have together received 3.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (15 papers), S100 Proteins and Annexins (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Acute Ischemic Stroke Management (3 papers), Immune Response and Inflammation (3 papers), Ginseng Biological Effects and Applications (2 papers), Respiratory Support and Mechanisms (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Clinical Biochemistry (2.1k citations), Endocrinology, Diabetes and Metabolism (950 citations), Nephrology (356 citations), Neurology (249 citations) and Immunology (404 citations). Ling Rong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ann Marie Schmidt, Thoralf Wendt, Loredana Bucciarelli, Shi Fang Yan, Wu Qu, David M. Stern, Yan Lü, Evanthia Lalla, Shi Du Yan and Thomas Kislinger. Their work appears in journals such as Journal of Clinical Investigation, Biomedicine & Pharmacotherapy, Respirology, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.